These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Renal function in renal or liver transplant recipients after conversion from a calcineurin inhibitor to sirolimus. Bäckman L; Reisaeter AV; Wramner L; Ericzon BG; Salmela K; Brattström C Clin Transplant; 2006; 20(3):336-9. PubMed ID: 16824151 [TBL] [Abstract][Full Text] [Related]
9. Stable kidney function in the second decade after kidney transplantation while on cyclosporine-based immunosuppression. Kandaswamy R; Humar A; Casingal V; Gillingham KJ; Ibrahim H; Matas AJ Transplantation; 2007 Mar; 83(6):722-6. PubMed ID: 17414704 [TBL] [Abstract][Full Text] [Related]
13. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients. Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237 [TBL] [Abstract][Full Text] [Related]
14. Calcineurin inhibitors in liver transplantation: to be or not to be. Castroagudín JF; Molina E; Varo E Transplant Proc; 2011; 43(6):2220-3. PubMed ID: 21839238 [TBL] [Abstract][Full Text] [Related]
15. Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: a prospective, randomized, multicenter trial. De Simone P; Metselaar HJ; Fischer L; Dumortier J; Boudjema K; Hardwigsen J; Rostaing L; De Carlis L; Saliba F; Nevens F Liver Transpl; 2009 Oct; 15(10):1262-9. PubMed ID: 19790150 [TBL] [Abstract][Full Text] [Related]
16. Differences in proteinuria and graft function in de novo sirolimus-based vs. calcineurin inhibitor-based immunosuppression in live donor kidney transplantation. Stephany BR; Augustine JJ; Krishnamurthi V; Goldfarb DA; Flechner SM; Braun WE; Hricik DE; Dennis VW; Poggio ED Transplantation; 2006 Aug; 82(3):368-74. PubMed ID: 16906035 [TBL] [Abstract][Full Text] [Related]
17. Absence of proteinuria predicts improvement in renal function after conversion to sirolimus-based immunosuppressive regimens in lung transplant survivors with chronic kidney disease. Stephany BR; Boumitri M; Budev M; Alao B; Poggio ED J Heart Lung Transplant; 2009 Jun; 28(6):564-71. PubMed ID: 19481016 [TBL] [Abstract][Full Text] [Related]
18. Sirolimus-based immunosuppression after cardiac transplantation: predictors of recovery from calcineurin inhibitor-induced renal dysfunction. Gustafsson F; Ross HJ; Delgado MS; Bernabeo G; Delgado DH J Heart Lung Transplant; 2007 Oct; 26(10):998-1003. PubMed ID: 17919619 [TBL] [Abstract][Full Text] [Related]
19. Calcineurin inhibitor substitution with sirolimus vs. reduced-dose calcineurin inhibitor plus sirolimus is associated with improved renal dysfunction in heart transplant patients. Potter BJ; Giannetti N; Edwardes MD; Cecere R; Cantarovich M Clin Transplant; 2007; 21(3):305-8. PubMed ID: 17488377 [TBL] [Abstract][Full Text] [Related]
20. Sirolimus as primary immunosuppressant for calcineurin inhibitor-related renal insufficiency after liver transplantation. Yang YJ; Li LX; He Q; Fan H; Jin ZK; Lang R; Kou JT; Li P; Xie DH; Chen DZ Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):376-8. PubMed ID: 17690032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]